Download het volledig rapport (302 p.) - KCE

KCE reports vol. 6A Prenatale zorg 137
Study Ref Population Intervention Outcomes Results Comments Study
type
EL
Infant death within 1 OR 0.87 (95% CI 0.27 to
year of birth (n = 711, 1 2.75)
RCT)
Infant death within 28 OR 0.60 (95% CI 0.05 to
days of birth (n = 744,
1 RCT)
6.60)
Incidence of stillbirth (n OR 0.48 (95% CI 0.09 to
= 748, 1 RCT) 2.47)
Incidence of preterm OR 0.21 (95% CI 0.05 to
delivery (n = 748, 1
RCT)
0.97)
Incidence of low birth OR 0.54 (95% CI 0.33 to
weight (n = 745, 1
RCT)
0.89)
Any side effects in child OR 0.69 (95% CI 0.27 to
(n = 739, 1 RCT) 1.76)
Maternal death (n = OR 0.40 (95% CI 0.02 to
717, 1 RCT)
9.93)
Any side effect in OR 0.73 (95% CI 0.17 to
mother (n = 764, 1
RCT)
3.06)
Infant death within 1 OR 0.71 (95% CI 0.36 to
year of birth (n = 616, 1 1.37)
RCT)
Incidence of stillbirth (n OR 0.49 (95% CI 0.04 to
= 631, 1 RCT) 5.40)
Incidence of low birth OR 1.50 (95% CI 0.75 to
weight (n = 601, 1
RCT)
3.01)
Maternal death (n = OR 0.33 (95% CI 0.01 to
618, 1 RCT)
8.14)
Shey 4 2 RCTs, known HIV infected Vitamin A
Stillbirths (n = 1692, 2 OR 1.07 (95% CI 0.63 to No evidence of SR 1a
Wiysonge et [618] women who are pregnant supplementation during RCTs)
1.80)
heterogeneity between